AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$AMPX

Stepien Thomas M sold $42K of AMPX

Stepien Thomas M (Chief Executive Officer) sold 2,000 shares of Amprius Technologies, Inc. (AMPX) at $20.97 on 2026-06-04.

Original reporting
SEC EDGAR · Stepien Thomas M
Published Jun 5, 2026, 8:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 5, 2026, 9:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$AMPX
Bearish
medium confidence
Mentioned
$AMPX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMPXBearishLow
01

Why it matters

The disclosure provides a concrete datapoint on insider behavior but does not include new operating/financial information.

02

Market read

Traders may reassess short-term sentiment around AMPX based on insider selling, but the magnitude is likely not decisive alone.

03

What to watch

Check for clustering of insider transactions over the prior 1–3 months and whether other insiders/major holders are also trimming.

Relevance 6/10Novelty 7/10Timing: Filed June 5; transaction dated June 4 (post-market disclosure).

Background

This is an SEC Form 4 insider transaction disclosure for Amprius Technologies (AMPX).

Company-level read

Ticker impact

$AMPXBearishMedium confidence
Context

CEO Stepien Thomas M sold 2,000 shares of Amprius Technologies on June 4 for ~$41.9k via an open-market sale.

Expected impact

Likely limited near-term impact; watch for follow-on selling or broader news.

Evidence & confidence

The filing discloses a specific insider transaction price/size, but insider sales alone rarely drive large repricing without accompanying fundamentals.

Market effects

Sector

Minimal; this is company-specific insider activity with no stated sector catalyst.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

A small open-market sale (and no stated 10b5-1 plan) can reflect diversification, taxes, or liquidity needs rather than bearish fundamentals.

Key entities

  • issuer
    Amprius Technologies, Inc.

    Subject of the Form 4 insider sale by its CEO.

  • insider
    Stepien Thomas M

    CEO and director who sold 2,000 shares on June 4.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

AMPX insider trading history →

Related articles

$AMPXMedAI 8/10

Amprius (AMPX) Q3 2026 Earnings Call Transcript

Amprius reported Q3 2026 revenue of $39.1M, up 83% YoY, raising its full-year target to $145M. The company introduced SiCore 500 cells for aviation and secured a $75M U.S. defense contract. Amprius expanded into maritime vehicles and partnered with U.S. manufacturers for NDAA-compliant production.

finance.yahoo.com
$AMPXMedAI 8/10

Amprius Technologies Q3 Earnings Call Highlights

Amprius reported a Q3 net loss of $3.5M, with adjusted EBITDA at -$1M. The company maintained its full-year gross margin forecast of 28% and expects Q4 sales of $43.3M. Amprius is expanding manufacturing to meet demand, with a $75M contract for a U.S. battery production line. It also introduced new products for aviation and deep-sea applications, ending Q3 with $60.7M in cash.

finance.yahoo.com
$AMPXHigh

Amprius Technologies falls 7% on third quarter earnings miss

Amprius Technologies (NYSE:AMPX) reported Q3 earnings missing estimates with a loss of $0.02 per share, though revenue of $39.1M beat expectations. Shares fell 7.7% after-hours. The company raised its full-year 2026 revenue outlook to $145M, above analyst forecasts. Gross profit rose 217% YoY to $10.5M, with gross margin improving to 27%. Amprius secured a $75M U.S. Department of War contract and introduced a new battery cell.

investing.com
$AMPXMed

Amprius Technologies Reports Third Quarter 2026 Financial Results and Recent

Amprius Technologies, Inc. (AMPX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Amprius Technologies Reports Third Quarter 2026 Financial Results and Recent Business Highlights • Q3 2026 revenue increased 83% year-over-year to $39.1 million • Net loss of $3.5 million, a 10% year-over-year improvement • Increasing 2026 revenue outlook to $145 mil

SEC EDGAR 8-K
$AMPXHigh

AMPX Stock Jumps As Defense Deals Supercharge Growth Story

Amprius Technologies Inc. (NYSE: AMPX) shares rose 8.38% on October 21, 2026, driven by U.S. Department of War funding and a partnership with Caminus for battery production. The company secured $75M in funding for a high-energy-density cell plant, with revenue growth but negative margins. Canaccord Genuity initiated coverage with a Buy rating and $14 price target.

stockstotrade.com